A Study of Intensity Modulated Radiation Therapy for Pelvic Lymph Nodes and Primary Tumour in Patients with Prostate Cancer

Official Title

A Phase I/II Study of Dose Escalated Intensity Modulated Radiation Therapy for the Treatment of Pelvic Lymph Nodes and Primary Tumour in Patients with Carcinoma of the Prostate.

Summary:

This is a single institution prospective phase I-II study.  All eligible patients with high risk prostate cancer who are going to have primary radiation therapy to the pelvic lymph nodes and prostate seminal vesicles with or without concurrent hormonal therapy will be approached regarding study entry.

Trial Description

Patients will be treated supine with an intensity modulated radiation therapy treatment plan. Patients will be planned using inverse planning techniques to maximize the dose to the CTV and minimize the dose to bladder and rectal walls, and femoral heads.

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

Resources

Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society